Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > For the weekend i.e. off topic -- covid related.
View:
Post by Pandora on Oct 01, 2021 8:26pm

For the weekend i.e. off topic -- covid related.

  When leronlimab gets approval later this year in Brazil, Fauci will have no defense for not approving a safe drug with a 6-year pristine safety profile that potentially improved the mortality by ~90%.  On just this one drug, the blood on his hands is hundreds of thousands of lives. But it is clear that he is a talking head—a politician first and doctor second—and that he will likely just make an attempt to save face.
 

CytoDyn (CYDY), on the other hand, is already receiving orders from the Philippines for leronlimab for treating COVID-19. These small biotech companies are paving the way to success in therapeutics to clean up the vaccine mess and provide patients and doctors with the tools they desperately need.

These two best of breed drugs, Tollovir and leronlimab, represent the complete lifecycle of the virus from infection to the cytokine storm.  One of these drugs should have been approved last year and indirectly Fauci’s focus on the vaccine destabilized the approval process, leaving therapeutics to fend for themselves without any government assistance.  Vaccine makers were provided money and given special treatment in the clinical trial approval process.  Providing people with a therapeutic choice would have been highly desirable, but that was in conflict with the vaccine-for-all policy decisions.  There are no approved therapeutics that work other than dexamethasone yet there are many in the pipeline. 

Fauci’s End Game

Fauci made a calculated, robotic move and went all in on vaccines.  He wanted to redeem himself from the AIDS crisis but instead, his gambit was crumbling all around him. Recently, Fauci has resorted to blaming unvaccinated individuals instead of taking responsibility for his vaccine Hail Mary with no backup plan. While unvaccinated individuals obviously won’t help combat the pandemic, Fauci seems more dedicated to maintaining his image than admitting to a failed strategy and helping promote other solutions for dying patients.  Breakthrough infections are Fauci’s undoing because people want to understand how getting sick but not dying is okay.  With all the news and excitement about Merck’s Molnupiravir, it's going to be hard for Fauci to stay silent on the topic. He may finally have to resign his position and admit that a vaccine only strategy was a massive gamble with human life.  His standard response seems to be that we need to look carefully at the data. That would be a tripling down on the Fauci gambit and a losing move.  The efficacy data on Molnupiravir is pretty good no matter how you slice it, but the safety and utility of use is really the issue.  Are there better safer options available?  For early to moderate Tollvir has the advantage and for severe to critical there is leronlimab.  Don’t expect Fauci to endorse anything other than a continuation of the vaccination process.  The combination of Molunpiravir, Tollovir, and leronlimab is going to lead to Fauci’s ultimate checkmate and removal.  The loss of human life as a result of his failed strategies is mind boggling and it won't take long for the press to turn on him with a death grip. 

 https://www.zerohedge.com/news/2021-10-01/mercks-therapeutics-waiting-wings-faucis-removal

Comment by Gooseybear on Oct 01, 2021 8:50pm
Fauci is a lying dog who cannot be trusted. 
Comment by Pandora on Oct 01, 2021 10:35pm
But he does remain as the total powerhouse for both the Biden government and all of the mainstream media. And there appears to be no way to change that, short of total failure in the vaccine regimen. It's cracking (breakthrough's) but it's not breaking - so far!
Comment by Yajne on Oct 01, 2021 11:17pm
Is that the same Fauci that to date has been another 'teflon man', ie nothing sticks to him? For example, the same Fauci who provided US funding for gain-of-function at the Wuhan lab? His removal can't happen soon enough IMO. The sheepl have been blindly following him over the cliff for many months now...
Comment by 99942Apophis on Oct 02, 2021 7:10am
Well I like to check both sides of accusations and here is something that seems to go against your argument, again I'm not taking sides just looking at both view points. FDA Torpedoes CytoDyn's Leronlimab for COVID-19 with Rare Public Scolding Published: May 18, 2021 By Mark Terry Al Drago/CQ Roll Call The U.S. Food and Drug Administration (FDA)  ...more  
Comment by Nailbiter1 on Oct 02, 2021 10:24am
This post has been removed in accordance with Community Policy
Comment by Pandora on Oct 02, 2021 12:13pm
And one minor item re the study -- the Company recommended 4 doses and the FDA said 'no, you may only use two'. I am not aware of a specific reason for the FDA to reduce the dosage. In the study the company found the effect tapered off too quickly after the first 14 days and they felt it would have been better with the 4 doses. The Brazil trial underway now is using the 4 dose regimen so ...more  
Comment by 99942Apophis on Oct 02, 2021 1:30pm
Yes Pandora it probably will do better with the 4 doses in Brazilian clinical trials. Regardless when Theralase does go into trial with their Coronavirus treatment it will do as well or in my opinion far better than the leading vaccines available currently and any drug. Good question is will Theralase's Coronavirus treatment be able to help those that are already infected with the virus mild ...more  
Comment by Oilminerdeluxe on Oct 02, 2021 1:40pm
So quiet about their virus research, one wonders if they have even started yet.
Comment by Pandora on Oct 02, 2021 3:50pm
https://umanitoba.ca/faculties/health_sciences/medicine/units/medical_microbiology/13328.html See the Dr. Kevi Coombs reference -- Laboratory Kevin Coombs -- although it does not give a progress report. Can't find anything re the National Research Lab in Winnipeg (JC Wilt)
Comment by Rumpl3StiltSkin on Oct 04, 2021 10:19am
Isn't this now being run by PHAC?
Comment by Pandora on Oct 03, 2021 2:01am
Another Li Ka Shing candidate -- anybody follow these guys: Sixth Wave (SIXW) has improved the sensitivity of its nanotechnology to detect the presence of the SARS-CoV-2 virus Reaching sensitivity measurements of 1,000,000 virus particles/mL means that infectious persons who are actively shedding the virus can be detected Research at the University of Alberta's Li Ka Shing ...more  
Comment by Pandora on Oct 02, 2021 3:08pm
What bothers me most is that we are a good 18 months past where all this started and regardless of now being around 80% fully vaccinated we in Canada still have 50 people a day dying from Covid (if stats can be believed). The main "therapeutic/medicine" that gets applied in the hospitals in Canada is Dexamethasone - an all purpose steroid? My wife was given this drug as an anti-nausea ...more  
Comment by Rumpl3StiltSkin on Oct 02, 2021 8:13pm
Well, Regardless of the FDA's stance on treatments for Covid vs vaccines, TLT's solution is both. ;-) We should know soon if it has any efficacy.
Comment by quesea on Oct 06, 2021 12:34am
You're both a Russian Bot & a stupid Republican for Idaho. LOL kc
Comment by gebremeskel on Oct 01, 2021 10:55pm
Off topic and also a steaming load of doodoo. Last time I checked it was the FDA that approves or disapproves drugs not Fauci. Anybody who posts here should know that, but what the hay, it's okay to post any nonsense you like about someone if he's been branded an ideological enemy by the right wing media.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250